Mitomycin approved for low-grade upper tract urothelial cancerApril 15, 2020Genitourinary CancerFDA Actions
FDA approves new drug for relapsed/refractory multiple myelomaMarch 2, 2020Lymphoma & Plasma Cell DisordersFDA Actions
FDA approves neratinib in combination for metastatic HER2-positive breast cancerFebruary 27, 2020Breast CancerFDA ActionsMetastatic Breast Cancer
